Literature DB >> 14976354

Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity.

Xun Song1, Carey Pope, Ramesh Murthy, Jamaluddin Shaikh, Bachchu Lal, Joseph P Bressler.   

Abstract

The effect of the organophosphorous insecticide paraoxon on the integrity of the blood-brain barrier (BBB) and permeability of pyridostigmine (PYR), a peripheral inhibitor of cholinesterase activity, was examined in Long Evans rats. The integrity of the BBB was examined by measuring the number of capillaries leaking horseradish peroxidase, which was injected into the heart. Treatment with paraoxon at 100 microg/kg, intramuscularly, resulted in a 3- to 4-fold increase in the number of leaky capillaries in young rats (25 to 30 days old) but not in older rats (90 days old). Interestingly, young rats treated with PYR (30 mg/kg, po) 50 min before treatment with paraoxon showed an inhibited effect of paraoxon on the BBB. Furthermore, no increase in the degree of inhibition of acetylcholinesterase activity was observed in young rats treated with PYR before paraoxon compared with young rats treated with paraoxon alone. Cholinergic toxicity, as assessed by changes in behavior, was not observed in young rats treated with paraoxon alone; but, slight signs of cholinergic toxicity were observed in rats treated with PYR. Young rats treated with both PYR and paraoxon did not exhibit more extensive signs of toxicity than rats treated with paraoxon alone or PYR alone. The results indicate that treatment with paraoxon can compromise BBB permeability at dosages that do not induce cholinergic toxicity, but only in young rats. Also, PYR pre-exposure appears to protect the BBB from the paraoxon-induced alterations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976354     DOI: 10.1093/toxsci/kfh076

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

1.  A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Eric M Prager; Camila P Almeida-Suhett; James P Apland; Maria F M Braga
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-15       Impact factor: 4.219

Review 2.  Possible role for anisodamine in organophosphate poisoning.

Authors:  Arik Eisenkraft; Avshalom Falk
Journal:  Br J Pharmacol       Date:  2016-04-22       Impact factor: 8.739

3.  Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair.

Authors:  Hila Israelov; Orly Ravid; Dana Atrakchi; Daniel Rand; Shirin Elhaik; Yael Bresler; Rachel Twitto-Greenberg; Liora Omesi; Sigal Liraz-Zaltsman; Fabien Gosselet; Michal Schnaider Beeri; Itzik Cooper
Journal:  J Neuroinflammation       Date:  2020-09-09       Impact factor: 8.322

4.  Dysfunction of 67-kDa Laminin Receptor Disrupts BBB Integrity via Impaired Dystrophin/AQP4 Complex and p38 MAPK/VEGF Activation Following Status Epilepticus.

Authors:  Hana Park; Seo-Hyeon Choi; Min-Jeong Kong; Tae-Cheon Kang
Journal:  Front Cell Neurosci       Date:  2019-05-24       Impact factor: 5.505

Review 5.  Antioxidant drug therapy as a neuroprotective countermeasure of nerve agent toxicity.

Authors:  Jennifer N Pearson-Smith; Manisha Patel
Journal:  Neurobiol Dis       Date:  2019-04-25       Impact factor: 5.996

6.  Endothelial Iron Homeostasis Regulates Blood-Brain Barrier Integrity via the HIF2α-Ve-Cadherin Pathway.

Authors:  Daniel Rand; Orly Ravid; Dana Atrakchi; Hila Israelov; Yael Bresler; Chen Shemesh; Liora Omesi; Sigal Liraz-Zaltsman; Fabien Gosselet; Taber S Maskrey; Michal Schnaider Beeri; Peter Wipf; Itzik Cooper
Journal:  Pharmaceutics       Date:  2021-02-28       Impact factor: 6.321

7.  Blood-Brain Barrier Cellular Responses Toward Organophosphates: Natural Compensatory Processes and Exogenous Interventions to Rescue Barrier Properties.

Authors:  Orly Ravid; Shirin Elhaik Goldman; David Macheto; Yael Bresler; Raquel Ines De Oliveira; Sigal Liraz-Zaltsman; Fabien Gosselet; Lucie Dehouck; Michal Schnaider Beeri; Itzik Cooper
Journal:  Front Cell Neurosci       Date:  2018-10-16       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.